Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia |
HR+HER2- Advanced Breast Cancer | Russian Federation | NCT06148506 | |
Dabrafenib and/or Trametinib Rollover Study |
Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers, High Grade Glioma | Phase4 | Hungary Spain United States |
NCT03340506 |
Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity |
Retinopathy of Prematurity | Korea, Republic of | NCT05304949 | |
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease |
Sickle Cell Disease | Phase1, Phase2 | United States | NCT06546670 |
A Post Marketing Surveillance on Piqray in Korea |
Breast Cancer | Korea, Republic of | NCT05293470 | |
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN |
IC-MPGN | Phase3 | Argentina Brazil Canada Czechia France Germany India Israel Italy Japan Poland Spain Switzerland Turkey United Kingdom United States Vietnam View All |
NCT05755386 |
A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids |
Primary Immune Thrombocytopenia | Phase3 | Argentina Australia Austria Belgium China Czechia France Germany Hungary India Italy Japan Korea, Republic of Malaysia Mexico Netherlands Norway Philippines Romania Singapore Spain Taiwan Thailand Turkey United Kingdom United States View All |
NCT05653219 |
A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission |
Non-radiographic Axial Spondyloarthritis | Phase4 | Belgium Brazil Colombia Czechia France Germany Hungary Israel Italy Malaysia Mexico Netherlands Philippines Poland Romania Thailand Turkey Vietnam View All |
NCT05622708 |
Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting |
Neovascular Age-related Macular Degeneration | United Arab Emirates | NCT05266495 | |
The Belgian REAL (BE.REAL) Registry |
Atherosclerotic Cardiovascular Disease | Belgium | NCT05726838 |